These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In silico prediction of chemical Ames mutagenicity. Xu C; Cheng F; Chen L; Du Z; Li W; Liu G; Lee PW; Tang Y J Chem Inf Model; 2012 Nov; 52(11):2840-7. PubMed ID: 23030379 [TBL] [Abstract][Full Text] [Related]
26. Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities. Contrera JF Regul Toxicol Pharmacol; 2011 Feb; 59(1):133-41. PubMed ID: 20933038 [TBL] [Abstract][Full Text] [Related]
27. Quantitative weight of evidence method for combining predictions of quantitative structure-activity relationship models. Tintó-Moliner A; Martin M SAR QSAR Environ Res; 2020 Apr; 31(4):261-279. PubMed ID: 32065534 [TBL] [Abstract][Full Text] [Related]
28. Utility of published DNA reactivity alerts. Myden A; Guesne SJ; Cayley A; Williams RV Regul Toxicol Pharmacol; 2017 Aug; 88():77-86. PubMed ID: 28549899 [TBL] [Abstract][Full Text] [Related]
29. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities. Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479 [TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of 11 in silico models for the prediction of small molecule mutagenicity: role of steric hindrance and electron-withdrawing groups. Ford KA; Ryslik G; Chan BK; Lewin-Koh SC; Almeida D; Stokes M; Gomez SR Toxicol Mech Methods; 2017 Jan; 27(1):24-35. PubMed ID: 27813437 [TBL] [Abstract][Full Text] [Related]
31. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view. Müller L; Singer T Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794 [TBL] [Abstract][Full Text] [Related]
32. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection. Witte I; Plappert U; de Wall H; Hartmann A Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584 [TBL] [Abstract][Full Text] [Related]
33. Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates. Hasselgren C; Bercu J; Cayley A; Cross K; Glowienke S; Kruhlak N; Muster W; Nicolette J; Reddy MV; Saiakhov R; Dobo K Regul Toxicol Pharmacol; 2020 Dec; 118():104807. PubMed ID: 33058939 [TBL] [Abstract][Full Text] [Related]
34. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens. Jacobson-Kram D; Contrera JF Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803 [TBL] [Abstract][Full Text] [Related]
35. Derivation and validation of toxicophores for mutagenicity prediction. Kazius J; McGuire R; Bursi R J Med Chem; 2005 Jan; 48(1):312-20. PubMed ID: 15634026 [TBL] [Abstract][Full Text] [Related]
36. Good statistics practice (GSP) in genetic toxicology. Khromov-Boris NN; Pêgas Henriques JA Mutat Res; 1998 Aug; 405(1):97-108. PubMed ID: 9729304 [No Abstract] [Full Text] [Related]
37. Random forest prediction of mutagenicity from empirical physicochemical descriptors. Zhang QY; Aires-de-Sousa J J Chem Inf Model; 2007; 47(1):1-8. PubMed ID: 17238242 [TBL] [Abstract][Full Text] [Related]
39. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations. Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561 [TBL] [Abstract][Full Text] [Related]
40. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities. Kovarich S; Cappelli CI Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]